




	
	  if (document.domain != 'www.netvibes.com') {	  
		  document.write(
'\n\t\n<style>\ndiv.vbp-widget * {\n    margin: 0;\n    padding: 0;\n    line-height:normal;\n    border:none;\n    text-transform:none;\n    \n}\n\ndiv.vbp-widget {\n    border: 1px solid #CCC;\n    color: #222;\n    margin: 0 auto;\n    background: #EEE;\n    font-family: \'Helvetica Neue\', Arial, sans-serif;\n    font-size: 12px;\n}\n\ndiv.vbp-widget a,\ndiv.vbp-widget a:link,\ndiv.vbp-widget a:visited {\n    text-decoration: none;\n    color: #35D;\n}\ndiv.vbp-widget a:hover {\n    text-decoration: underline;\n} \n\n/**** header ****/\n\ndiv.vbp-widget .vbp-header {\n    background: #DDD;\n    height: 44px;\n    border-bottom: 1px solid #BBB;\n    background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x top left;\n    padding: 5px 15px;\n}\n\ndiv.vbp-widget p.vbp-company {\n    padding-top: 3px;\n    margin-right: 140px;\n    float: left;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-company a {\n}\ndiv.vbp-widget .vbp-company a * {\n    display: block;\n}\n\ndiv.vbp-widget .vbp-company a strong {\n    font-size: 18px;\n    color: #333;\n    text-shadow: 0 2px 1px #FFF;\n    font-weight: bold;\n}\ndiv.vbp-widget .vbp-company a em {\n    font-style: normal;\n    font-size: 11px;\n    color: #346;\n}\n\ndiv.vbp-widget a img {\n    border: none;\n}\n\ndiv.vbp-widget .vbp-header img, div.vbp-widget .vbp-header a img {\n    float: right;\n    border: 1px solid #CCC;\n}\n\ndiv.vbp-widget p.vbp-utility {\n    width: 120px;\n    float: right;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-utility a {\n    display: block;\n    padding: 2px 5px;\n    font-size: 11px;\n    -moz-border-radius: 3px;\n\t-webkit-border-radius: 3px;\n    margin-right: 5px;\n    margin-bottom: 3px;\n}\ndiv.vbp-widget .vbp-utility a:link,\ndiv.vbp-widget .vbp-utility a:visited {\n    background: rgba(0,0,0,.08);\n    color: #111;\n    text-shadow: 0 1px 1px hsla(0,0%,100%,1);\n}\ndiv.vbp-widget .vbp-utility a:hover {\n    background: #459;\n    color: #FFF;\n    text-decoration: none;\n    text-shadow: none;\n}\n\n/**** content ****/\n\ndiv.vbp-widget div.vbp-content {\n    padding: 8px 0;\nbackground-color:#fff;\n}\n\ndiv.vbp-widget .vbp-col {\n    width: 46%;\n    float: left;\n    margin: 0 2%;\n}\n\ndiv.vbp-widget div.vbp-content p,\ndiv.vbp-widget div.vbp-content h5 {\n    padding-left: 5px;\n}\n\ndiv.vbp-widget p {\n\tmargin-top: 0px;\n  font-size: 12px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-categogy {\n    clear: both;\n    margin-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content h5 {\n    font-size: 12.5px;\n    background: #F4F4F4;\n    color: #444;\n    padding-top: 2px;\n    padding-bottom: 2px;\n    background: #F4F4F4 url(http://venturebeatprofiles.com/images/widget_heading_bg.gif) repeat-x left bottom;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p {\n    border-top: 1px dotted #E4E4E4;\n    padding-top: 4px;\n    padding-bottom: 4px;\n    margin:0;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p strong {\n    font-size: 11px;\n    text-transform: uppercase;\n    color: #88A;\n}\n\ndiv.vbp-widget div.vbp-content a:link,\ndiv.vbp-widget div.vbp-content a:visited {\n    color: #35D;\n}\ndiv.vbp-widget div.vbp-content a:hover {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-description, div.vbp-widget p.vbp-description-long, div.vbp-widget p.vbp-description-short {\n    padding-top: 2px;\n    padding-bottom: 8px;\n}\n\ndiv.vbp-widget .vbp-description img, div.vbp-widget .vbp-description-long img div.vbp-widget .vbp-description-short img {\n    float: left;\n    border: 1px solid #CCC;\n    margin: 0 8px 8px 0;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news {\n    margin-bottom: 0;\n    padding-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p {\n    padding-top: 4px;\n    padding-bottom: 4px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a {\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a * { display: block; }\n\ndiv.vbp-widget div.vbp-content .vbp-news p a em {\n    font-size: 10px;\n    text-transform: uppercase;\n    font-style: normal;   \n    color: #666;\n    letter-spacing: 0.08em;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a strong {\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover {\n    text-decoration: none;\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover * {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-footer {\n    border-top: 1px solid #CCC;\n    padding: 5px 10px;\n    color: #888;\n    height: 15px;\n    font-size: 11px;\n    text-shadow: 0 1px 1px #FFF;\n}\n\ndiv.vbp-widget .vbp-footer a {\n}\n\ndiv.vbp-widget .vbp-header,\ndiv.vbp-widget .vbp-footer {\n  background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x left top;\n}\n\n/**** clearfix ****/\n\n.clearfix:after {\n  content: \'\';\n  display: block;\n  height: 0;\n  clear: both;\n  visibility: hidden;\n }\n\n.tradevibes_hidden, .vbp-hide {\n\tdisplay:none !important;\n}\n</style>\n\n\n\n\n<script type="text/javascript">\n\tvar tv_long_cls = \'vbp-description-long\';\n\tvar tv_short_cls = \'vbp-description-short\';\n\tvar tv_hid = \'vbp-hide tradevibes_hidden\';\n\tfunction tradevibes_toggle_description(e) {\n\t\tvar targ;\n\t\tif (!e) var e = window.event;\n\t\tif (e.target) targ = e.target;\n\t\telse if (e.srcElement) targ = e.srcElement;\n\t\tif (targ.nodeType == 3) // defeat Safari bug\n\t\t\ttarg = targ.parentNode;\n\n\t\tvar parent = targ.parentNode;\n\t\tif (parent.className.indexOf(tv_short_cls) != -1) {\n\t\t\t// short description is visible\n\t\t\tparent.className = tv_hid + \' \' + tv_short_cls;\n\t\t\tvar sibling = parent.nextSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.nextSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_long_cls;\n\t\t}  else {\n\t\t\tparent.className = tv_hid + \' \' + tv_long_cls;\n\t\t\tvar sibling = parent.previousSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.previousSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_short_cls;\n\t\t}\n\t}\n</script>\n\n\n<div class="vbp-widget" id="visioncare-ophthalmic-technologies" title="VisionCare Ophthalmic Technologies">\n\t<div class="vbp-header">\n\n\t\t<a class="tradevibes_logo vbp-logo " href="http://venturebeatprofiles.com/company/profile/visioncare-ophthalmic-technologies?src=widget" title="VisionCare Ophthalmic Technologies">\n\t<img src="http://venturebeatprofiles.com/ugenimage/logo/company_5359/16803.png" alt="VisionCare Ophthalmic Technologies" title="VisionCare Ophthalmic Technologies" width="82" height="40">\n</a>\n\n\n\t\t<p class="vbp-company">\n\t\t\t<a href="http://venturebeatprofiles.com/company/profile/visioncare-ophthalmic-technologies?src=widget"><strong>VisionCare Ophthalmic Technologies</strong></a>\n\t\t\t<a href="http://www.visioncareinc.net/" target="_blank"><em>http://www.visioncareinc.net/</em></a>\n\t\t</p>\n\t\t<p class="vbp-utility">\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/account/profile/add_watch/visioncare-ophthalmic-technologies?src=widget">Watch Company</a>\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/company/widget/preview/visioncare-ophthalmic-technologies?src=widget">Get Widget</a>\n\t\t</p>\n\t</div><!-- header -->\n\t<div class="vbp-content clearfix">\n\t\t<div class="vbp-left-col vbp-col">\n\n\t\t\t<p class="vbp-description vbp-description-short tradevibes_short_description">VisionCare Ophthalmic Technologies (VisionCare) is a privately-held development stage company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic...<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">More&raquo;</a></p>\n\t\t\t<p class="vbp-description vbp-description-long vbp-hide tradevibes_hidden">VisionCare Ophthalmic Technologies (VisionCare) is a privately-held development stage company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.  The Company has developed and is currently sponsoring clinical trials of the Implantable Miniature Telescope (IMT\u2122 by Dr. Isaac Lipshitz), an ocular prosthetic device designed to improve the central vision of patients who have bilateral moderate to severe central vision loss due to age-related macular degeneration (AMD) and other macular disorders.<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">&laquo;Less</a></p>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Overview</h5>\n\t\t\t\t<p><strong>Location:</strong> \tSaratoga, CA, United States\n</p>\n\t\t\t\t<p><strong>Industry:</strong> Medical Devices &amp; Equipment</p>\n\t\t\t\t<p><strong>Tags:</strong>\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=medical">medical</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=eyes">eyes</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=optical">optical</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=IMT">IMT</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=macular+degeneration">macular degeneration</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Financials</h5>\n\t\t\t\t<p><strong>Latest Funding:</strong> Series D - $20M (01/05/2005)</p>\n\t\t\t\t<p><strong>Investors:</strong>\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/infinity-venture-capital?src=widget">Infinity Venture Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/israel-infinity-venture-capital?src=widget">Israel Infinity Venture Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/onset-ventures?src=widget">Onset Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/peregrine-ventures?src=widget">Peregrine Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/pitango-venture-capital?src=widget">Pitango Venture Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/three-arch-partners?src=widget">Three Arch Partners</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/boston-scientific?src=widget">Boston Scientific</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/clal-industries-and-investments?src=widget">Clal Industries and Investments</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\t\t</div><!-- col -->\n\t\t<div class="vbp-right-col vbp-col">\n\n\t\t\t<div class="vbp-news">\n\t\t\t\t<h5>Recent News</h5>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/visioncare-ophthalmic-technologies?article=117208">\n\t\t\t\t\t<em>Apr  1, 2009</em>\n\t\t\t\t\t<strong>Tech Ticker: VisionCare, Cisco, Microsoft</strong>\n\t\t\t\t</a></p>\n\t\t\t</div>\n\n\t\t</div><!-- col -->\n\t</div><!-- content -->\n\t<p class="vbp-footer">\n\t\t<a href="http://venturebeatprofiles.com/company/profile/visioncare-ophthalmic-technologies?src=widget">VisionCare Ophthalmic Technologies Company Profile</a> powered by <a href="http://venturebeatprofiles.com/?src=widget">VentureBeat Profiles</a>.\n\t</p>\n</div><!-- widget -->\n'
);
		  if (typeof tradevibes_post == "function") {
			  tradevibes_post();
		  }
	  }






